Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonist.
第一作者:
Yanping,Xu
第一单位:
Division of Eli Lilly & Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA.
作者:
主题词
投药, 口服(Administration, Oral);动物(Animals);载脂蛋白A-Ⅰ(Apolipoprotein A-I);结合, 竞争性(Binding, Competitive);生物利用度(Biological Availability);细胞系(Cell Line);狗(Dogs);药物设计(Drug Design);人类(Humans);小鼠(Mice);小鼠, 转基因(Mice, Transgenic);丙酸盐类(Propionates);放射配体测定(Radioligand Assay);大鼠(Rats);受体, 胞质和核(Receptors, Cytoplasmic and Nuclear);构效关系(Structure-Activity Relationship);转录因子(Transcription Factors);转染(Transfection);三唑类(Triazoles)
DOI
10.1021/jm034173l
PMID
14613314
发布时间
2004-11-17
- 浏览8
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文